BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9224330)

  • 1. A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer.
    Barry MJ; Fowler FJ; Bin L; Oesterling JE
    J Urol; 1997 Aug; 158(2):488-91; discussion 492. PubMed ID: 9224330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians.
    Collins MM; Barry MJ; Bin L; Roberts RG; Oesterling JE; Fowler FJ
    J Gen Intern Med; 1997 Apr; 12(4):224-9. PubMed ID: 9127226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1997 American Urological Association Gallup survey: Changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997.
    Gee WF; Holtgrewe HL; Blute ML; Miles BJ; Naslund MJ; Nellans RE; O'Leary MP; Thomas R; Painter MR; Meyer JJ; Rohner TJ; Cooper TP; Blizzard R; Fenninger RB; Emmons L
    J Urol; 1998 Nov; 160(5):1804-7. PubMed ID: 9783961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice patterns of Canadian urologists in benign prostatic hyperplasia and prostate cancer. Canadian Prostate Health Council.
    Ramsey EW; Elhilali M; Goldenberg SL; Nickel CJ; Norman R; Perreault JP; Piercy B; Trachtenberg J
    J Urol; 2000 Feb; 163(2):499-502. PubMed ID: 10647665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines.
    Paick JS; Kim SW; Ku JH
    Yonsei Med J; 2007 Apr; 48(2):281-8. PubMed ID: 17461528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States.
    Gee WF; Holtgrewe HL; Albertsen PC; Litwin MS; Manyak MJ; O'Leary MP; Painter MR
    J Urol; 1995 Jul; 154(1):205-6. PubMed ID: 7539861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population.
    Strope SA; Elliott SP; Saigal CS; Smith A; Wilt TJ; Wei JT;
    Urology; 2011 Jul; 78(1):3-9. PubMed ID: 21601254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of symptomatic BPH in Italy: who is treated and how?
    Tubaro A; Montanari E
    Eur Urol; 1999; 36 Suppl 3():28-32. PubMed ID: 10559628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
    Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
    J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer.
    Fawzy A; Fontenot C; Guthrie R; Baudier MM
    Fam Med; 1997 May; 29(5):321-5. PubMed ID: 9165283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Korean urologist's view of practice patterns in diagnosis and management of benign prostatic hyperplasia: a nationwide survey.
    Oh CY; Lee SH; Yoo SJ; Chung BH
    Yonsei Med J; 2010 Mar; 51(2):248-52. PubMed ID: 20191018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice patterns regarding prostate cancer and benign prostatic hyperplasia in Japanese primary care practitioners.
    Fukagai T; Maruyama K; Nagata M; Morita M; Naoe M; Yoshida H
    Int J Urol; 2007 May; 14(5):412-5. PubMed ID: 17511723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
    McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
    Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current urological practice: routine urological examination and early detection of carcinoma of the prostate.
    Thompson IM; Zeidman EJ
    J Urol; 1992 Aug; 148(2 Pt 1):326-9; discussion 329-30. PubMed ID: 1635128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of benign prostatic hyperplasia management by urologists and nonurologists: a Korean nationwide health insurance database study.
    Park J; Lee YJ; Lee JW; Yoo TK; Chung JI; Yun SJ; Hong JH; Seo SI; Cho SY; Son H
    Korean J Urol; 2015 Mar; 56(3):233-9. PubMed ID: 25763128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current trends in prostate cancer diagnosis and staging among United States urologists.
    Plawker MW; Fleisher JM; Vapnek EM; Macchia RJ
    J Urol; 1997 Nov; 158(5):1853-8. PubMed ID: 9334616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
    JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Who works in the prevention and early detection of benign prostatic hyperplasia and prostate cancer in Croatia?].
    Kranjcević K; Marković BB
    Acta Med Croatica; 2007 Feb; 61(1):45-8. PubMed ID: 17593640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes of European urologists to early prostatic carcinoma, II. Attitude to therapy and to screening examinations.
    Hansen MV; Grönberg A
    Eur Urol; 1995; 28(3):196-201. PubMed ID: 8536772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians.
    Sausville J; Naslund M
    Int J Clin Pract; 2010 Dec; 64(13):1740-5. PubMed ID: 21070524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.